Servaes SE, Hoffer FA, Smith EA, Khanna G. Imaging of Wilms tumor: an update. Pediatr Radiol. 2019 Oct. 49 (11):1441-52. [QxMD MEDLINE Link].
Coppes MJ, Pritchard-Jones K. Principles of Wilms' tumor biology. Urol Clin North Am. 2000 Aug. 27(3):423-33, viii. [QxMD MEDLINE Link].
Knudson AG, Strong LC. Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst. 1972 Feb. 48(2):313-24. [QxMD MEDLINE Link].
Coppes MJ, Haber DA, Grundy PE. Genetic events in the development of Wilms' tumor. N Engl J Med. 1994 Sep 1. 331(9):586-90. [QxMD MEDLINE Link].
Coppes MJ, Huff V, Pelletier J. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr. 1993 Nov. 123(5):673-8. [QxMD MEDLINE Link].
Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005 Oct 10. 23(29):7312-21. [QxMD MEDLINE Link].
Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol. 1993. 21(3):172-81. [QxMD MEDLINE Link].
Cunningham ME, Klug TD, Nuchtern JG, et al. Global disparities in Wilms tumor. J Surg Res. 2020 Mar. 247:34-51. [QxMD MEDLINE Link].
Heck JE, Park AS, Contreras ZA, et al. Risk of childhood cancer by maternal birthplace: a test of the Hispanic paradox. JAMA Pediatr. 2016 Jun 1. 170 (6):585-92. [QxMD MEDLINE Link].
Green DM. The treatment of stages I-IV favorable histology Wilms' tumor. J Clin Oncol. 2004 Apr 15. 22(8):1366-72. [QxMD MEDLINE Link].
Montgomery BT, Kelalis PP, Blute ML, et al. Extended followup of bilateral Wilms tumor: results of the National Wilms Tumor Study. J Urol. 1991 Aug. 146(2 ( Pt 2)):514-8. [QxMD MEDLINE Link].
Paulino AC, Wilimas J, Marina N, et al. Local control in synchronous bilateral Wilms tumor. Int J Radiat Oncol Biol Phys. 1996 Oct 1. 36(3):541-8. [QxMD MEDLINE Link].
Paulino AC, Thakkar B, Henderson WG. Metachronous bilateral Wilms' tumor: the importance of time interval to the development of a second tumor. Cancer. 1998 Jan 15. 82(2):415-20. [QxMD MEDLINE Link].
Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006 May 20. 24(15):2352-8. [QxMD MEDLINE Link].
Green DM, Cotton CA, Malogolowkin M, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. May/ 2007. 48:493-9. [QxMD MEDLINE Link].
Malogolowkin M, Cotton CA, Green DM, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2008 Feb. 50(2):236-41. [QxMD MEDLINE Link].
Green DM, Donckerwolcke R, Evans AE, D'Angio GJ. Late effects of treatment for Wilms tumor. Hematol Oncol Clin North Am. 1995 Dec. 9(6):1317-27. [QxMD MEDLINE Link].
Egeler RM, Wolff JE, Anderson RA, Coppes MJ. Long-term complications and post-treatment follow-up of patients with Wilms' tumor. Semin Urol Oncol. 1999 Feb. 17(1):55-61. [QxMD MEDLINE Link].
Evans AE, Norkool P, Evans I, et al. Late effects of treatment for Wilms' tumor. A report from the National Wilms' Tumor Study Group. Cancer. 1991 Jan 15. 67(2):331-6. [QxMD MEDLINE Link].
Lange J, Peterson SM, Takashima JR, et al. Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. J Urol. 2011 Aug. 186(2):378-86. [QxMD MEDLINE Link]. [Full Text].
Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys. 2000 Mar 15. 46(5):1239-46. [QxMD MEDLINE Link].
Lange JM, Takashima JR, Peterson SM, Kalapurakal JA, Green DM, Breslow NE. Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study. Cancer. 2014 Dec 1. 120 (23):3722-30. [QxMD MEDLINE Link].
Gibson TM, Mostoufi-Moab S, Stratton KL, Leisenring WM, Barnea D, Chow EJ, et al. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2018 Dec. 19 (12):1590-1601. [QxMD MEDLINE Link].
van den Heuvel-Eibrink MM, Grundy P, Graf N, et al. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups. Pediatr Blood Cancer. 2008 Jun. 50(6):1130-4. [QxMD MEDLINE Link].
Refaie HD, Sarhan M, Hafez A. Role of CT in assessment of unresectable Wilms' tumor response after preoperative chemotherapy in pediatrics. ScientificWorldJournal. 2008 Jul 13. 8:661-9. [QxMD MEDLINE Link].
Mitchell C, Pritchard-Jones K, Shannon R, et al. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group. Eur J Cancer. 2006 Oct. 42(15):2554-62. [QxMD MEDLINE Link].
Reinhard H, Semler O, Burger D, et al. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Klin Padiatr. 2004 May-Jun. 216(3):132-40. [QxMD MEDLINE Link].
Coppes MJ, Arnold M, Beckwith JB, et al. Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group. Cancer. 1999 Apr 1. 85(7):1616-25. [QxMD MEDLINE Link].
D'Angio GJ, Breslow N, Beckwith JB, et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989 Jul 15. 64(2):349-60. [QxMD MEDLINE Link].
Kalapurakal JA, Li SM, Breslow NE, et al. Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' tumor Study Group. Int J Radiat Oncol Biol Phys. 2003. 57:495-9. [QxMD MEDLINE Link].
Green DM, Breslow NE, Beckwith JB, et al. Treatment with nephrectomy only for small, stage I/favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. Sep 1/ 2001. 19:3719-24. [QxMD MEDLINE Link].
Meisel JA, Guthrie KA, Breslow NE, Donaldson SS, Green DM. Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys. 1999 Jun 1. 44(3):579-85. [QxMD MEDLINE Link].
Grundy PE, Green DM, Dirks AC, et al. Clinical significance of pulmonary nodules detected by CT and not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012 Oct. 59(4):631-5. [QxMD MEDLINE Link]. [Full Text].
Verschuur A, Van Tinteren H, Graf N, Bergeron C, Sandstedt B, de Kraker J. Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy. J Clin Oncol. 2012 Oct 1. 30(28):3533-9. [QxMD MEDLINE Link].
Hamilton TE, Ritchey ML, Haase GM, et al. The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group. Ann Surg. 2011 May. 253(5):1004-10. [QxMD MEDLINE Link].
D'Angio GJ, Rosenberg H, Sharples K, et al. Position paper: imaging methods for primary renal tumors of childhood: costs versus benefits [published erratum appears in Med Pediatr Oncol 1993;21(9):695]. Med Pediatr Oncol. 1993. 21(3):205-12. [QxMD MEDLINE Link].
Pritchard-Jones K, Bergeron C, de Camargo B, et al. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet. 2015 Sep 19. 386 (9999):1156-64. [QxMD MEDLINE Link].
Green DM. Doxorubicin in stage II-III, intermediate-risk Wilms' tumour. Lancet. 2015 Sep 19. 386 (9999):1118-9. [QxMD MEDLINE Link].